The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for cysteamine hydrochloride (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
cysteamine hydrochloride
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Eye drops, solution
Indication
Treatment of corneal cystine deposits in cystinosis in adults and children over two years of age
Therapeutic area
Ophthalmology